Repertoire Immune Medicines Revenue and Competitors
Estimated Revenue & Valuation
- Repertoire Immune Medicines's estimated annual revenue is currently $15.3M per year.
- Repertoire Immune Medicines's estimated revenue per employee is $155,000
- Repertoire Immune Medicines's total funding is $257.3M.
Employee Data
- Repertoire Immune Medicines has 99 Employees.
- Repertoire Immune Medicines grew their employee count by -45% last year.
Repertoire Immune Medicines's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP, Protein Engineering and Molecular Sciences | Reveal Email/Phone |
2 | Head Platform Discovery and Technology | Reveal Email/Phone |
3 | Head Legal and Intellectual Property | Reveal Email/Phone |
4 | EVP and CMO | Reveal Email/Phone |
5 | Associate Director, Controller | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Associate Director | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | EVP, Chief Human Resources Officer | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
Repertoire Immune Medicines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $50.8M | 328 | 3% | N/A | N/A |
What Is Repertoire Immune Medicines?
We are Repertoire Immune Medicines – a Flagship Pioneering company working to unleash the remarkable power of the human immune system. We seek to harness the intrinsic ability of T cells to prevent and cure disease. Our mission is a challenging one, requiring a complex and multi-dimensional approach that integrates cutting-edge biology and sophisticated, novel technologies. We stand ready to meet this challenge with our unique platforms, world-class team and unparalleled network of researchers, clinicians, academics and entrepreneurs.
keywords:N/A
$257.3M
Total Funding
99
Number of Employees
$15.3M
Revenue (est)
-45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Repertoire Immune Medicines News
... experience in pharmaceutical and biotechnology companies to Evelo. ... Executive Officer and President of Repertoire Immune Medicine and...
... Cellarity, Repertoire Immune Medicines, Third Rock Ventures, Ochre Bio, FL82, Relation Therapeutics Limited, and Dahlia Biosciences.
Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases, today announced the completion of a $189 million Series B financing. Joining Flagship Pioneerin ...
Repertoire Immune Medicines, a newly launched company working to surface the power of the immune system to prevent and cure disease, received an investment from the JDRF T1D Fund. The amount of the deal was not disclosed. The company intends to use the funds to utilize its core platforms to di ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.9M | 99 | 25% | N/A |
#2 | $28.7M | 99 | 4% | N/A |
#3 | $21.8M | 99 | 8% | N/A |
#4 | $28.7M | 99 | 4% | N/A |
#5 | $21.4M | 100 | -27% | $525.5M |